Ceftragod S 500mg/250mg Injection
Marketer
Godase Healthcare
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Ceftragod S 500mg/250mg Injection
Ceftragod S, a 500mg/250mg injectable combination drug, combats diverse bacterial infections by inhibiting microbial growth and propagation. Administration must be strictly under medical supervision; missed doses should be avoided, and the prescribed course completed regardless of symptom improvement. Premature cessation may compromise efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) demand prompt medical care. Inform your physician of all concurrent medications before commencing treatment. Expectant and nursing mothers require prior medical consultation. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, drowsiness or dizziness mandates abstention from driving. Adequate rest, proper nutrition, and hydration are crucial for optimal recovery. Your doctor may order lab tests and imaging to monitor treatment effectiveness.
Primary Ingredients of Ceftragod S 500mg/250mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Ceftragod S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Ceftragod S 500mg/250mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Ceftragod S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ceftragod S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Ceftragod S 500mg/250mg Injection works:
Ceftragod S 500mg/250mg Injection unites Ceftriaxone, a crucial antibiotic, with Sulbactam, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam's role is to counteract bacterial resistance mechanisms, thereby bolstering Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Ceftragod S 500mg/250mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Ceftragod S (500mg/250mg) is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, clinical data from human trials are scarce.
Breast feedingCAUTION
Administering Ceftragod S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Mothers should temporarily discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administration of Ceftragod S 500mg/250mg Injection can induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ceftragod S 500mg/250mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Individuals with severe hepatic impairment should use Ceftragod S 500mg/250mg Injection cautiously, potentially requiring dosage modification. Medical advice is recommended. Dosage alteration of Ceftragod S 500mg/250mg Injection is unnecessary for those with mild to moderate liver dysfunction.
What if you forget to take Ceftragod S 500mg/250mg Injection :
Should you inadvertently omit a scheduled dose of Ceftragod S 500mg/250mg Injection, seek advice from your physician.
Facts to Know About Ceftragod S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently